|Dr. David Ross Parkinson||Pres, CEO & Director||626.81k||N/A||1950|
|Mr. David S. Wood||Chief Financial Officer||311.52k||N/A||1957|
|Mr. Peter A. Virsik||Exec. VP & COO||544.66k||N/A||1971|
|Dr. Marianne D. Sadar||Scientific Advisor||136.05k||N/A||1961|
|Dr. Alessandra Cesano||Chief Medical Officer||N/A||N/A||N/A|
ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
ESSA Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.